IQ-AI LTD. LS -01 Market Cap ($123.35K)
Market Cap & Net Worth: IQ-AI LTD. LS -01 (5Y1)
IQ-AI LTD. LS -01 market cap. IQ-AI LTD. LS -01 (F:5Y1) has a market capitalization of $123.35K (€105.51K) as of November 3, 2026. Listed on the F stock exchange, this Germany-based company holds position #31470 globally and #2801 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying IQ-AI LTD. LS -01's stock price €0.00 by its total outstanding shares 246709789 (246.71 Million). Also see IQ-AI LTD. LS -01 operating cash flow efficiency for how efficiently the company converts equity into cash flow.
IQ-AI LTD. LS -01 Market Cap History (2021–2026)
IQ-AI LTD. LS -01 market cap history from 2021 to 2026. Data shows change from $16.73 Million to $144.21K (-60.27% CAGR). Check IQ-AI LTD. LS -01 stock price for real-time trading data and today's change.
IQ-AI LTD. LS -01 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how IQ-AI LTD. LS -01's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of IQ-AI LTD. LS -01 to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.18x
IQ-AI LTD. LS -01's market cap is 0.18 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $16.73 Million | $521.07K | -$501.06K | 32.11x | N/A |
| 2022 | $3.75 Million | $535.89K | -$511.60K | 7.00x | N/A |
| 2023 | $11.10 Million | $609.39K | -$623.82K | 18.22x | N/A |
| 2024 | $2.16 Million | $750.11K | -$327.10K | 2.88x | N/A |
| 2025 | $144.21K | $788.15K | -$400.94K | 0.18x | N/A |
Competitor Companies of 5Y1 by Market Capitalization
Companies near IQ-AI LTD. LS -01 in the global market cap rankings as of November 3, 2026. Also see total assets of IQ-AI LTD. LS -01 for a full breakdown of the balance sheet.
Key companies related to IQ-AI LTD. LS -01 by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #719 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1627 globally with a market cap of $14.50 Billion USD ( AU$20.50 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2005 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2067 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #719 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $312.96 |
| #1627 | Pro Medicus Ltd | AU:PME | $14.50 Billion | AU$196.20 |
| #2005 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $72.22 |
| #2067 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $66.89 |
Market Capitalization of IQ-AI LTD. LS -01 (2021–2026)
Market capitalization of IQ-AI LTD. LS -01 from 2021 to today. Between 2021 and today, IQ-AI LTD. LS -01's market cap moved from $16.73 Million to $ 144.21K, with a yearly change of -60.27%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €144.21K | 0.00% |
| 2025 | €144.21K | -93.33% |
| 2024 | €2.16 Million | -80.52% |
| 2023 | €11.10 Million | +196.15% |
| 2022 | €3.75 Million | -77.59% |
| 2021 | €16.73 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 2nd, 2026 the market cap of IQ-AI LTD. LS -01 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $123.35K USD |
| MoneyControl | $123.35K USD |
| MarketWatch | $123.35K USD |
| marketcap.company | $123.35K USD |
| Reuters | $123.35K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About IQ-AI LTD. LS -01
Imaging Biometrics Ltd. provides clinical treatments to patients in the field of medical imaging diagnostics in the United Kingdom, China, the European Union, South America, Australia, and the United States. It operates through Holding Company, Medical Software, Oral Gallium Maltolate (GaM), and Organ-on-a-Chip segments. The company develops ready-to-use software applications comprising IB Neuro,… Read more